Expectations of patients suffering from idiopathic pulmonary fibrosis about their treatment: results of the French national survey, RESPIR
A. Bourdin (Montpellier, France), E. Bergot (Caen, France), H. Nunes (Bobigny, France), G. Prévot (Toulouse, France), B. Wallaert (Lille, France), S. Marchand-Adam (Tours, France), V. Cottin (Lyon, France)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bourdin (Montpellier, France), E. Bergot (Caen, France), H. Nunes (Bobigny, France), G. Prévot (Toulouse, France), B. Wallaert (Lille, France), S. Marchand-Adam (Tours, France), V. Cottin (Lyon, France). Expectations of patients suffering from idiopathic pulmonary fibrosis about their treatment: results of the French national survey, RESPIR. 1405
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: